EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tailored Iron Oxide Nanoparticles as Potential Cannabinoid Carriers for Anti-Cancer Treatment

Jan Taudul iD, Joanna Celej iD, Kinga Żelechowska-Matysiak iD, Daria Kępińska, Agnieszka Majkowska-Pilip iD, Marcin Strawski iD, Paweł Krysiński iD, Dorota Nieciecka

Biomolecules · 2025

DOI: 10.3390/biom15020230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Jan Taudul und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, University of Warsaw, Ludwika Pasteura 1, 02-093 Warsaw, Poland. Hauptthemen laut MEDLINE: Cannabinoids, Drug Carriers, Magnetic Iron Oxide Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present a novel, multicomponent nanoparticulate carrier system based on superparamagnetic iron oxide nanoparticles with a designed hydrophilic/hydrophobic balance based on oleic acid and TWEEN 80 to incorporate hydrophobic cannabinoids—cannabigerol and cannabidiol—as well as the hydrophilic anthracycline drug epirubicin, forming a conjugate anticancer system. Additionally, the superparamagnetic iron oxide-based nanoparticles formed the core of the system, thus providing it with magnetic hyperthermia capabilities with a specific absorption rate comparable to the corresponding systems in the literature. The interaction of the conjugate with the cell membrane was studied using the Langmuir monolayers at the air/water interface formed of selected lipids modeling the healthy and cancerous cell membranes. Finally, cytotoxicity tests were carried out against the SKOV-3 cell line in vitro. A synergistic effect was observed when both the cannabinoid and epirubicin were present in the conjugate, as compared to the cannabinoid or epirubicin alone, making our system advantageous for further development for tentative therapeutic use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabinoidsDrug CarriersMagnetic Iron Oxide NanoparticlesAntineoplastic AgentsHumansCell Line, TumorEpirubicinCannabidiolCell SurvivalHydrophobic and Hydrophilic Interactions

Stichwörter der Autor:innen

cannabinoidsepirubiciniron oxide nanoparticlesnanocarriers

Substanzen

CannabinoidsDrug CarriersAntineoplastic AgentsEpirubicinCannabidiol

Autor:innen und Institutionen

  • Faculty of Chemistry, University of Warsaw, Ludwika Pasteura 1, 02-093 Warsaw, Poland.
  • Institute of Physical Chemistry of the Polish Academy of Sciences, Marcina Kasprzaka 44/52, 01-224 Warsaw, Poland.
  • Centre of Radiochemistry and Nuclear Chemistry, Institute of Nuclear Chemistry and Technology, Dorodna 16, 03-195 Warsaw, Poland.
  • Biotech Evolution, Mokra 3C, 05-092 Łomianki, Poland.

ORCID-Profile: Jan Taudul, Joanna Celej, Kinga Żelechowska-Matysiak, Agnieszka Majkowska-Pilip, Marcin Strawski, Paweł Krysiński

Zitieren

APA

Taudul, J., Celej, J., Żelechowska-Matysiak, K., Kępińska, D., Majkowska-Pilip, A., Strawski, M., Krysiński, P., & Nieciecka, D. (2025). Tailored Iron Oxide Nanoparticles as Potential Cannabinoid Carriers for Anti-Cancer Treatment. Biomolecules. https://doi.org/10.3390/biom15020230

Vancouver

Taudul J, Celej J, Żelechowska-Matysiak K, Kępińska D, Majkowska-Pilip A, Strawski M, et al. Tailored Iron Oxide Nanoparticles as Potential Cannabinoid Carriers for Anti-Cancer Treatment. Biomolecules. 2025. doi:10.3390/biom15020230

BibTeX
@article{Taudul2025,
  author = {Taudul, Jan and Celej, Joanna and Żelechowska-Matysiak, Kinga and Kępińska, Daria and Majkowska-Pilip, Agnieszka and Strawski, Marcin and Krysiński, Paweł and Nieciecka, Dorota},
  title = {Tailored Iron Oxide Nanoparticles as Potential Cannabinoid Carriers for Anti-Cancer Treatment},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15020230}
}
Kostenlos starten →